$LQDA

Krepp Sarah sold $1.7M of LQDA

Krepp Sarah (Chief Human Resource Officer) sold 24,880 shares of Liquidia Corp (LQDA) at $70.28 ($1.75M total) across 2 trades on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Krepp Sarah
Published Jun 15, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LQDA
Neutral
medium confidence
Mentioned
$LQDA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralLow
01

Why it matters

The newest concrete fact is the officer’s open-market sale details (shares, price, total value) and confirmation of a pre-arranged 10b5-1 plan.

02

Market read

This provides incremental ownership/flow information for LQDA but does not introduce a new fundamental catalyst.

03

What to watch

Traders may overreact to insider sales; without accompanying guidance/clinical/regulatory updates, the signal is usually weak.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-15; transaction dated 2026-06-11

Background

The article is an SEC Form 4 insider transaction disclosure for Liquidia Corp.

Company-level read

Ticker impact

$LQDANeutralMedium confidence
Context

Liquidia Corp (LQDA) disclosed an officer open-market sale: 24,880 shares sold by Chief Human Resource Officer Sarah Krepp under a 10b5-1 plan.

Expected impact

Likely limited/short-lived impact; treat as sentiment noise unless accompanied by other fundamental news.

Evidence & confidence

The filing is a routine Form 4 insider transaction with a stated 10b5-1 plan, reducing interpretive weight versus non-plan sales.

Market effects

No sector-level read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect liquidity/compensation mechanics rather than bearish expectations.

Key entities

  • Liquidia Corp

    Company whose Form 4 insider sale was disclosed.

  • Sarah Krepp

    Chief Human Resource Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LQDAHighAI 8/10

Why is Liquidia stock cratering today?

Liquidia Corporation's stock fell 48.3% to $36.55 after a court ruled it infringed two claims of United Therapeutics' patent, impacting its YUTREPIA drug. The company plans to remove a key indication and may face further restrictions. United Therapeutics' stock rose. The broader market gained slightly.